Background: Accumulated experimental evidence suggests that resveratrol may have an
effect on diabetic nephropathy by inhibiting inflammation and decreasing oxidative stress …

As one of the most common complications of diabetes, nephropathy develops in
approximately 40% of diabetic individuals. Although end stage kidney disease is known as …

Diabetic nephropathy (DN), the leading cause of end-stage renal disease, is the most
significant microvascular complication of diabetes and poses a severe public health concern …

Diabetic kidney disease (DKD) is the main cause of end-stage renal disease worldwide, and
there is a lack of effective treatment strategies. Autophagy is a highly conserved lysosomal …

Glomerular diseases are major components of kidney disease, mainly manifested as
podocyte disease, immune complex-associated glomerulonephritis, and renal autoimmune …

Background Diabetic kidney disease (DKD) is a major complication of diabetes and the
leading cause of end-stage renal disease worldwide. Renal inflammation and infiltration of …

Diabetic kidney disease (DKD) is one of the most common complications of diabetes, and its
prevalence is still growing rapidly. However, the efficient therapies for this kidney disease …

Background Diabetes and cancer have common physiological and biochemical
mechanisms. Metformin is the preferred drug of choice for the treatment of diabetes. Prostate …

Background Using inulin can enhance resveratrol's effects by improving the intestinal
microbiome and the stability of resveratrol. Objectives We aimed to investigate the effect of …

Diabetic nephropathy (DN) is one of the most serious complications in diabetic patients. And
m6A modifications mediated by METTL3 are involved multiple biological processes …